Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Bank Hapoalim (IsraCard)'s primary investment focus by sector?
- According to startupim data, Bank Hapoalim (IsraCard) shows a strong concentration in Fintech & Insurtech, with 3 portfolio companies and 3 investment rounds in this sector. They also have significant activity in Health Tech & Life Sciences.
- Can you name some of Bank Hapoalim (IsraCard)'s notable portfolio companies?
- Bank Hapoalim (IsraCard)'s portfolio includes Diagnostic Robotics, which has raised $79M, and EarlySense, which has raised $140M. For a full list, please refer to startupim.
- What was Bank Hapoalim (IsraCard)'s most recent investment activity?
- Bank Hapoalim (IsraCard)'s most recent investments were in Feezback Technologies in August 2022, where they invested $2.5M as a lead investor, and in Diagnostic Robotics in July 2022, with a $45M investment.
- Has Bank Hapoalim (IsraCard) acted as a lead investor in any rounds?
- Yes, Bank Hapoalim (IsraCard) has acted as a lead investor in at least two rounds: in Feezback Technologies in August 2022 with a $2.5M investment, and in Wecheck in May 2018 with a $12M investment.
- What is the typical investment range for Bank Hapoalim (IsraCard)?
- According to startupim data, Bank Hapoalim (IsraCard)'s investment range is between $2.5M and $55M.
- When did Bank Hapoalim (IsraCard) make its first recorded investment?
- Bank Hapoalim (IsraCard) made its first recorded investment in June 2016, in EarlySense, with an amount of $25M.
- What is Bank Hapoalim (IsraCard)'s investment activity like across different funding stages?
- Bank Hapoalim (IsraCard) has invested across various stages, including Seed, A Round, B Round, C Round (as a follow-on), D Round, and G Round, with multiple investments in A and B rounds.
- Are there any notable exits from Bank Hapoalim (IsraCard)'s portfolio?
- According to startupim data, there is no information available regarding exits from Bank Hapoalim (IsraCard)'s portfolio.